Thiel, Jens <br/><br/>
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).  [electronic resource] 

 -  Arthritis research & therapy  Sep 2013 
 - R133 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar4313  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Antineutrophil Cytoplasmic--blood<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>B-Lymphocyte Subsets--drug effects<br/>C-Reactive Protein--metabolism<br/>Churg-Strauss Syndrome--blood<br/>Drug Resistance<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin E--blood<br/>Immunosuppressive Agents--therapeutic use<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome